Arcturus Therapeutics

ARCT · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 26 days ago

Total Revenue

$7.2M

Previous year: $22.8M

-68.4%

EPS

-$1.03

Previous year: -$1.11

-7.2%

R&D Expenses

$24.5M

Previous year: $43.8M

-44.1%

G&A Expenses

$14M

Previous year: $12.4M

Loading...

Arcturus Therapeutics

Unlock previous datapoints

Upgrade

Arcturus Therapeutics

Unlock previous datapoints

Upgrade

Arcturus Therapeutics Revenue by Segment

Revenue by Segment

Collaboration Revenue

CapyFin.com

Grant Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$192M

P/E Ratio

-2.84

Sector

N/A

Industry

N/A

52-Week High

$23.1

52-Week Low

$5.89

R&D Expenses

$24.5M

G&A Expenses

$14M

Total Cash Position

$233M

Restricted Cash

$1.89M

Accounts Receivable

$5.56M

Products

Get in Touch

Resources

Arcturus Therapeutics

Arcturus Therapeutics

Arcturus Therapeutics

Arcturus Therapeutics Revenue by Segment

Revenue by Segment

Collaboration Revenue

Grant Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics